These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37923598)

  • 41. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
    Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
    J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-depth investigation of the mechanisms of Echinacea purpurea polysaccharide mitigating alcoholic liver injury in mice via gut microbiota informatics and liver metabolomics.
    Jiang W; Zhu H; Liu C; Hu B; Guo Y; Cheng Y; Qian H
    Int J Biol Macromol; 2022 Jun; 209(Pt A):1327-1338. PubMed ID: 35461865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum IgA levels and IgA/IgG ratio in Alcoholic Liver Disease.
    BhatB NM
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
    Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.
    Kim W; Jeong D; Chung J; Lee D; Joo S; Jang ES; Choi YJ; Yoon H; Shin CM; Park YS; Jeong SH; Kim N; Lee DH; Kim JW
    Sci Rep; 2019 Mar; 9(1):3236. PubMed ID: 30824851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of a new model to diagnose an alcohol basis for steatohepatitis.
    Dunn W; Angulo P; Sanderson S; Jamil LH; Stadheim L; Rosen C; Malinchoc M; Kamath PS; Shah VH
    Gastroenterology; 2006 Oct; 131(4):1057-63. PubMed ID: 17030176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample.
    Koch M; Freitag-Wolf S; Schlesinger S; Borggrefe J; Hov JR; Jensen MK; Pick J; Markus MRP; Höpfner T; Jacobs G; Siegert S; Artati A; Kastenmüller G; Römisch-Margl W; Adamski J; Illig T; Nothnagel M; Karlsen TH; Schreiber S; Franke A; Krawczak M; Nöthlings U; Lieb W
    Eur J Clin Nutr; 2017 Aug; 71(8):995-1001. PubMed ID: 28378853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.
    Masarone M; Troisi J; Aglitti A; Torre P; Colucci A; Dallio M; Federico A; Balsano C; Persico M
    Metabolomics; 2021 Jan; 17(2):12. PubMed ID: 33458794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recovery of ethanol-induced
    Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
    Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between alcoholic liver disease and HCV infection.
    Takase S; Takada N; Sawada M; Tsutsumi M; Takada A
    Alcohol Alcohol Suppl; 1993; 1A():77-84. PubMed ID: 8141926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.
    Kang KH; Kim JH; Kang SH; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Gut Liver; 2015 Mar; 9(2):224-30. PubMed ID: 25473073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Zhong X; Cui P; Jiang J; Ning C; Liang B; Zhou J; Tian L; Zhang Y; Lei T; Zuo T; Ye L; Huang J; Chen H
    Front Cell Infect Microbiol; 2021; 11():649060. PubMed ID: 33816353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting.
    Said A; Williams J; Holden J; Remington P; Musat A; Lucey MR
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):928-34. PubMed ID: 15476157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
    Naveau S; Emilie D; Balian A; Grangeot-Keros L; Borotto E; Portier A; Giraud V; Capron F; Galanaud P; Chaput JC
    J Hepatol; 1998 May; 28(5):778-84. PubMed ID: 9625312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum and urinary metabolomics and outcomes in cirrhosis.
    Bajaj JS; Fan S; Thacker LR; Fagan A; Gavis E; White MB; Heuman DM; Fuchs M; Fiehn O
    PLoS One; 2019; 14(9):e0223061. PubMed ID: 31560724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total fasting serum bile acids and beta-hexosaminidase in alcoholic liver disease.
    Joelsson B; Hultberg B; Isaksson A; Alwmark A; Gullstrand P; Bengmark S
    Clin Chim Acta; 1984 Jan; 136(2-3):203-9. PubMed ID: 6229367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.
    Stewart SH; Reuben A; Anton RF
    Alcohol Alcohol; 2017 Jan; 52(1):24-28. PubMed ID: 27998920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.